CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-19 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-09-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −4,000 | $411.08 | $1.6M | 130 |
| 2025-09-19 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 254,000 | ||
| 2025-09-19 | Olian Judy D. Director | Sale | −1,800 | $415.43 | $748K | 5,045 |
| 2025-09-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion 10b5-1 | +11,000 | $135.42 | $1.5M | 47,781 |
| 2025-09-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −400 | $402.50 | $161K | 47,381 |
| 2025-09-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,100 | $404.33 | $445K | 46,281 |
| 2025-09-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,973 | $405.45 | $1.2M | 43,308 |
| 2025-09-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −3,222 | $406.39 | $1.3M | 40,086 |
| 2025-09-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,105 | $407.42 | $858K | 37,981 |
| 2025-09-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,200 | $408.11 | $490K | 36,781 |
| 2025-09-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion · Stock Option 10b5-1 | −11,000 | 55,000 | ||
| 2025-09-18 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-09-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $403.27 | $807K | 2,130 |
| 2025-09-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,121 | $405.20 | $454K | 1,009 |
| 2025-09-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −879 | $406.04 | $357K | 130 |
| 2025-09-18 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 258,000 | ||
| 2025-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,135 | $399.97 | $1.3M | 995 |
| 2025-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −865 | $400.90 | $347K | 130 |
Page 200 of 214 · 4,273 trades